Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding ...
Leadership
Jian Irish M.B.A., Ph.D.
CEO, President & Director
Brian Charles Thomas Ph.D.Founder
Co-Founder & Director
Pamela M. Wapnick M.B.A.
Chief Financial Officer
Matthew L. Wein J.D.
General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary
Joseph Knowles M.D.Founder
Co-Founder & Member of Scientific Advisory Board
Mark Leonard
Senior Vice President of Technical Development & Operations
Alan Brooks Ph.D.
Senior Vice President of Research
Katalin Kauser M.D., Ph.D.
Senior Vice President of Translational Biology
